Paclitaxel Actavis 6 mg/ml koncentrat till infusionsvätska
Sponsors
Karolinska University Hospital, F. Hoffmann-La Roche AG, Uppsala University Hospital
Conditions
Colorectal cancer with peritoneal metastasesNon-metastatic HER2-positive Breast CancerPersistent or Recurrent Rare Epithelial Ovarian Tumors
Phase 2
A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer: ARIADNE
RecruitingCTIS2022-501504-95-00
Start: 2023-06-23Target: 402Updated: 2025-08-18
A Phase II, Open-Label, Multicenter, Platform Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients with Persistent or Recurrent Rare Epithelial Ovarian Tumors
Active, not recruitingCTIS2023-508194-89-00
Start: 2021-08-30Target: 57Updated: 2026-01-06
COLOVERT – Conversion therapy in colorectal cancer with peritoneal metastases not amenable to upfront cytoreductive surgery and HIPEC: a phase II “pick-the-winner” open-label randomized trial
Not yet recruitingCTIS2026-526122-41-00
Target: 60Updated: 2026-07-15